Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| QIAGEN NV | 11 | 0 | 1 | 0 | €40.47 | €47.44 | 17.223% |
| NanoViricides Inc. | 1 | 1 | 1 | 0 | €2.00 | €3.00 | 50.000% |
| Laboratorios Farmaceuticos | 1 | 0 | 0 | 0 | €87.50 | €100.00 | 14.286% |
| GSK plc ADR | 6 | 0 | 2 | 0 | €36.20 | €49.33 | 36.263% |
| Gilead Sciences Inc | 11 | 1 | 1 | 0 | €70.96 | €85.27 | 20.172% |
| Sanofi S.A. | 3 | 0 | 0 | 0 | €96.23 | €99.50 | 3.398% |
| Pfizer Inc. | 29 | 4 | 2 | 0 | €27.54 | €41.29 | 49.946% |
| Ionis Pharmaceuticals Inc. | 26 | 5 | 6 | 0 | €47.83 | €56.86 | 18.884% |
| Geron Corp. | 16 | 0 | 0 | 0 | €3.96 | €5.10 | 28.871% |
| Ocuphire Pharma Inc. | 6 | 1 | 0 | 0 | €1.88 | €18.37 | 875.877% |
| Xencor Inc. | 14 | 1 | 0 | 0 | €19.60 | €31.70 | 61.717% |
| arGEN X BV | 1 | 0 | 0 | 0 | €449.80 | €470.00 | 4.491% |
| Fate Therapeutics Inc. | 4 | 3 | 1 | 0 | €4.97 | €7.31 | 46.972% |
| Charles River Labs Intl | 12 | 0 | 1 | 0 | €204.60 | €248.57 | 21.491% |
| Exelixis Inc. | 20 | 0 | 2 | 0 | €21.16 | €26.01 | 22.904% |
| Anika Therapeutics | 5 | 0 | 0 | 0 | €25.80 | €28.29 | 9.654% |
| Corcept Therapeutics Inc. | 15 | 0 | 1 | 0 | €31.83 | €36.87 | 15.828% |
| Amarin Corp. ADR | 2 | 1 | 0 | 0 | €0.73 | - | - |
| Neurocrine Bioscience | 35 | 0 | 4 | 0 | €134.65 | €143.34 | 6.457% |
| AnaptysBio Inc | 9 | 1 | 1 | 0 | €34.60 | €46.24 | 33.642% |
| X4 Pharmaceuticals, Inc. | 7 | 0 | 1 | 0 | €0.79 | €4.61 | 480.479% |
| Blueprint Medicines Corp | 1 | 0 | 0 | 0 | €104.80 | - | - |
| SCYNEXIS Inc. | 5 | 0 | 0 | 0 | €1.92 | €8.35 | 334.363% |
| Lexicon Pharmaceuticals Inc. | 5 | 0 | 1 | 0 | €2.15 | €9.17 | 326.115% |
| Immunogen Inc. | 4 | 0 | 0 | 0 | €28.97 | - | - |